Award
NIH Reporter #2P50CA254838-06
The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
Recipient
SLOAN-KETTERING INST CAN RESEARCH
Award Amount
$3,031,373.00
Ceiling
$3,031,373.00
Awarded
September 17, 2026
Identifier
2P50CA254838-06
Supports leukemia research focused on new targeted and immune therapies for acute myeloid leukemia, including clinical trials and studies of treatment resistance.
Description
Funding for the MSK SPORE in Leukemia to develop targeted therapies and immunotherapeutic approaches for acute myeloid leukemia, investigate treatment response and resistance, and conduct four translational research projects supported by shared resource cores.